Dihydroergotamine nasal and Morphine Extended-Release Capsules
Determining the interaction of Dihydroergotamine nasal and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Morphine Immediate-Release Tablets and Capsules
- Dihydroergotamine nasal-Morphine injection
- Dihydroergotamine nasal-Morphine Injection PF
- Dihydroergotamine nasal-Morphine Long-Acting Tablets
- Dihydroergotamine nasal-Morphine Oral Concentrate (20 mg/mL)
- Dihydroergotamine nasal-Morphine Oral Solution
- Morphine Extended-Release Capsules-Dihydroergotamine Nasal Spray
- Morphine Extended-Release Capsules-Dilacor XR
- Morphine Extended-Release Capsules-Dilantin
- Morphine Extended-Release Capsules-Dilantin Infatabs
- Morphine Extended-Release Capsules-Dilantin injection
- Morphine Extended-Release Capsules-Dilantin Kapseals